Ad
Monday, 14 May 2018
U.S. considering expanding Medicare drug price negotiation
NEW YORK (Reuters) - The U.S. is considering expanding Medicare's ability to negotiate the cost of drugs, Health and Human Services Secretary Alex Azar said in prepared remarks on Monday that followed up on President Trump's speech on drug pricing last week.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment